Randomized, Double-Blind, Placebo-Controlled, Parallell-Group, 12-Month Trial of Leuco-methythionium bis(hydromethanesulfonate) in Subjects With Mild to Moderate Alzheimer's Disease

Conditions

Alzheimer´s Disease

What is the purpose of this trial?

The purpose of this study is to determine the safety and efficacy of Leuco-methylthionium bis(hydromethanesulfonate) in the treatment of subjects with mild to moderate Alzheimer's Disease


Participation Guidelines

Age:
Up to 89 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
TauRx Therapeutics, Ltd
Dates:
12/2012 - 3/15
Last Updated:
Study HIC#:
1303011645